References
- Cliffton E. E., Goodner J. T., Bronstein E. Preoperative irradiation for cancer of the esophagus. Cancer 1960; 13: 37–45
- Colloby P. S., West K. P., Fletcher A. Is poor prognosis really related to HLA-DR-expression by malignant melanoma cells. Histopathology 1992; 20: 411–416
- Doyle C, Strominger J. L. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 1987; 330: 256–259
- Esteban F., Ruiz-Cabello F., Concha A., Pérez-Ayala H., Sánchez-Rozao J. A., Garrido F. HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx. Clinical and Experimental Metastasis 1990; 8: 319–328
- Glew S. S., Duggan-Keen M., Cabera T., Stern P. L. HLA class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Research 1992; 52: 4009–4016
- Guerry D. I. V., Alexander M. A., Herlyn M. F., Zehengebot L. M., Mitchell K. F., Zmuewski C. H., Lusk E. H. HLA-DR histocompatibility leukocyte antigen permit cultured human melanoma cells from eary but not advanced disease to stimulate autologous lymphocye. Journal of Clinical Investigation 1984; 73: 267–271
- Kamma H., Yazawa T., Ogata T., Haraguchi H., Iijima T. Expression of MHC class II antigen in human lung cancer cells. Virchows Archives B. Cell Pathology 1991; 60: 407–412
- Kitamura K., Kuwano H., Matsuda H., Toh T., Masuda H., Sugimachi K. Synergistic effects of intral-tumoral administration of cis-diamminedichloro platinum (II) combined with local hyperthermia in melanoma bearing mice. Journal of Surgical Oncology 1992; 51: 188–194
- Krensky A. M., Weiss A., Crabtree G., Davis M. M., Parham P. T-lym-phocyte-antigen interations in transplant rejection. New England Journal of Medicine 1990; 322: 510–517
- Kuwano H., Sumiyoshi K., Watanabe M., Sadanaga N., Nozoe T., Yasuda M., Sugimachi K. Preoperative hyperthermia combined with chemotherapy and irradiation for the treatment of patients with oesophageal carcinoma. Tumori 1995; 81: 18–22
- Mattijssen V., De Mulder P. H., Schalkwijk L., Manni J. J., Hof-Grootenboer B. V., Ruiter D. J. HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites. International Journal of Cancer 1991; 49: 95–100, (suppl 6)
- Möller P., Momburg F., Koretz K., Moldenhauer G., Herfarth C., Otto H. F., Hämmerling G. J., Schlag P. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma. Cancer Research 1991; 51: 729–736
- Muller J. M., Ersmi H., Stelzen M., Zieren U., Pichlmaier H. Surgical therapy of oesophageal carcinoma. British Journal of Surgery 1990; 77: 845–847
- Natali P. C., De Martino C., Quaranta V., Bigotti A., Pellegrino M. A., Ferrone S. Changes in la-like antigen expression on malignant human cells. Immunogenetics 1981; 12: 409–413
- Nuchtern J. G., Biddison W. E., Klausner R. D. Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature 1990; 343: 74–76
- Ohno S., Korenaga D., Kuwano H., Mori M., Sugimachi K. DNA aneuploidy assessment of the effectiveness of hyperthermo-chemo-radiotherapy for eso-phageal carcinoma. Cancer 1989; 63: 1951–1955
- Ohno S., Morita M., Tsutsui S., Matsuura H., Kuwano H., Maekawa Y., Sugimachi K. Correlation between hyperthermoradiosensitivity and clinical effect in carcinoma of the esophagus. Surgical, Gynecological Obstetrics 1990; 171: 472–476
- Sadanaga N., Kuwano H., Watanabe M., Maekawa S., Mori M., Sugimachi K. Local immune response to tumor invasion in esophageal squamous cell carcinoma. The expression of human leukocyte antigen-DR and lymphocyte infiltration. Cancer 1994; 74: 586–591
- Stockinger B., Pessara U., Lin R. H., Habicht J., Grez M., Koch N. A role of Ia-associated invariant chains in antigen proceeding and presentation. Cell 1989; 56: 683–689
- Sugimachi K., Inokuchi K., Kai H., Sogawa A., Kawai Y. Endotractantenna for application of hyperthermia to malignant lesions. Gann 1983; 74: 104–106
- Sugimachi K., Matsuda H., Ohno S., Fukuda A., Matsuoka H., Mori M., Kuwano H. Long term effects of hyperthermia combined with chemotherapy and irradiation for the treatment of patients with carcinoma of the esophagus. Surgical, Gynecological Obstetrics 1988; 167: 319–323
- Teh M., Lee Y. S. HLA-DR antigen expression in intestinal-type and diffuse-type gastric carcinoma. Cancer 1992; 69: 1104–1107
- Torii A., Harada A., Nakao A., Nonami T., Nakayama A., Ito M., Takagi H. Expression of HLA-DR in intrahepatic cholangiocarcinoma. Cancer 1992; 70: 1057–1061